| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $451.4M | +146.7% |
| R&D Expense | $64.3M | +20.5% |
| SG&A Expense | $427.3M | +80.1% |
| Operating Income | -$71.0M | +41.1% |
| Interest Expense | $8.9M | +13.8% |
| Pre-tax Income | -$64.4M | +44.3% |
| Income Tax | $2.1M | — |
| Net Income | -$66.4M | +42.5% |
| EPS (Basic) | -$1.59 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $183.6M | +93.7% |
| Short-term Investments | $233.6M | +18.9% |
| Accounts Receivable | $85.1M | +81.9% |
| Inventory | $4.4M | +66.9% |
| Current Assets | $522.8M | +46.6% |
| Total Assets | $562.2M | +49.1% |
| Current Liabilities | $135.7M | +68.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.5M | +85.0% |
| Capital Expenditures | $9.9M | +529.2% |
| Investing Cash Flow | -$42.1M | +78.9% |
| Financing Cash Flow | $143.4M | -7.3% |
| Free Cash Flow | -$22.3M | +73.6% |
| +48.2% |
| EPS (Diluted) | -$1.59 | +48.2% |
| Long-term Debt |
| $72.4M |
| +0.8% |
| Total Liabilities | $218.7M | +43.5% |
| Stockholders' Equity | $343.4M | +53.0% |